The advanced cardiac imaging team, comprised of cardiologists, radiologists and bioengineers, has been developing new techniques and novel frameworks for understanding acquired and congenital heart disease in innovative and clinically useful ways. We have made major advancements in understanding single ventricle heart disease and pulmonary hypertension:
- In single ventricle heart disease, our team has been able to use cardiac MRI to link ventricular dyssynchrony, aortic arch geometry and flow propagation through the body to important clinical outcomes. This provides important insights into how CMR could be used to help predict adverse outcomes.
- In children and adolescents with pulmonary hypertension, our team has used a combination of 2D, 3D and 4D imaging based on echocardiography and cardiac MRI platforms to validate new ways to measure the many facets of cardiac muscle function. Following these metrics over time helps us identify patients at risk for acute events before they happen.
- Pre-surgical planning of congenital heart disease using 3D echocardiography has advanced our understanding of heart valve repairs and complex surgical baffle repairs for complex congenital heart disease. We are the primary research site for the 3D consortium in the nation and a leading site within the industry to develop pediatric 2D and 3D ultrasound probes.
- 3D echocardiography-guided catheter interventions in congenital heart disease has reduced radiation use. Our team uses fusion imaging to reduce the amount of radiation exposure of our congenital heart disease patients and we are the leading research program in developing this advanced fusion imaging tool to better understand congenital heart disease and structural heart interventions.